tiprankstipranks
Trending News
More News >
Dyne Therapeutics (DYN)
NASDAQ:DYN
US Market

Dyne Therapeutics (DYN) Income Statement

Compare
416 Followers

Dyne Therapeutics Income Statement

Last quarter (Q3 2025), Dyne Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Dyne Therapeutics's net income was $-108.04M. See Dyne Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.24M$ -2.46M$ 0.00$ 0.00$ -700.00K
Operating Expenses
$ 341.64M$ 239.70M$ 170.96M$ 150.03M$ 57.95M
Depreciation and Amortization
$ 2.24M$ 2.46M$ 1.68M$ 1.09M$ 700.00K
EBITDA
$ -315.18M$ -233.48M$ -169.28M$ -148.94M$ -58.34M
Operating Income
$ -343.89M$ -242.16M$ -170.96M$ -150.03M$ -58.65M
Other Income/Expenses
$ 26.47M$ 6.22M$ 2.86M$ 734.00K$ -790.00K
Pretax Income
$ -317.42M$ -235.94M$ -168.10M$ -149.29M$ -59.44M
Net Income
$ -317.42M$ -235.94M$ -168.10M$ -149.29M$ -58.74M
Per Share Metrics
Basic EPS
$ -3.37$ -3.95$ -3.23$ -2.93$ -1.24
Diluted EPS
$ -3.37$ -3.95$ -3.23$ -2.93$ -1.24
Weighted Average Shares Outstanding
94.14M 59.68M 51.98M 50.90M 47.27M
Weighted Average Shares Outstanding (Diluted)
94.14M 59.68M 51.98M 50.90M 47.27M
Currency in USD

Dyne Therapeutics Earnings and Revenue History